D. Karlin

发表

A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors.

L. Coussens, H. Rugo, N. Sharma, 2014 .

Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.

S. Legha, G. Bodey, A. Bedikian, 1983, American journal of clinical oncology.

5‐Fluorouracil, adriamycin, and mitomycin‐C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas

B. Levin, P. Woolley, P. Schein, 1980, Cancer.

Quality of Extemporaneously Compounded Nitroglycerin Ointment

D. Azarnoff, D. Karlin, J. Lee, 2007, Diseases of the colon and rectum.

Comparison of colon cleansing methods in preparation for colonoscopy.

C. E. Brady, D. Stewart, J. Dipalma, 1984, Gastroenterology.

Cis-diaminodichloroplatinum (II) chemotherapy for advanced adenocarcinoma of the upper gastrointestinal tract.

J. Ajani, H. Kantarjian, D. Karlin, 1985, Oncology.

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

L. Coussens, H. Rugo, N. Sharma, 2019, Therapeutic advances in medical oncology.

Chemotherapy for colorectal cancer with a combination of PALA and 5-FU.

G. Bodey, A. Bedikian, M. Valdivieso, 1981, Cancer treatment reports.

Fecal skatole and indole and breath methane and hydrogen in patients with large bowel polyps or cancer

J. Stroehlein, A. Mastromarino, D. Karlin, 1985, Journal of Cancer Research and Clinical Oncology.

Breath methane excretion in patients with unresected colorectal cancer.

J. Stroehlein, A. Mastromarino, D. Karlin, 1982, Journal of the National Cancer Institute.

Trophic Effects of Gastrin on Colorectal Neoplasms in the Rat

M. Romsdahl, D. Mcgregor, D. Karlin, 1982, Annals of surgery.

Meningeal metastasis from rectal carcinoma with elevated cerebrospinal fluid carcinoembryonic antigen

R. Bresalier, D. Karlin, 1979, Diseases of the colon and rectum.

Hypergastrinemia and colorectal carcinogenesis in the rat.

M. Romsdahl, D. Karlin, R. Jones, 1985, Cancer letters.

Comparison of effects of pentagastrin and gastrin on rat colon mucosa.

M. Romsdahl, D. Mcgregor, D. Karlin, 1983, The Journal of surgical research.

Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.

O. Lipatov, J. Eckardt, H. Breitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged survival and effective palliation in patients with squamous cell carcinoma of the esophagus following endoscopic laser therapy

R S Fisher, B. Krevsky, R. Fisher, 1987, Cancer.

BRIDGE: An open-label phase II trial evaluating the safety of bevacizumab (BV) plus paclitaxel/carboplatin (PC) as first-line treatment (tx) for patients (pts) with advanced, previously untreated, squamous non-small cell lung cancer (NSCLC).

J. Hainsworth, L. Fang, L. Faoro, 2010 .

Effect of enprostil on the gastroduodenal mucosa of healthy volunteers

J. Isenberg, M. Robinson, P. Basuk, 1990, Alimentary pharmacology & therapeutics.

Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.

M. Socinski, D. Spigel, D. Waterhouse, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RASH, NEPHRITIS, HYPERTENSION, AND HÆMOLYSIS IN PATIENT ON 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN-C

D. Karlin, J. Stroehlein, 1980, The Lancet.

CIS-platinum chemotherapy for advanced gastrointestinal cancer

J. Stroehlein, L. Heifetz, D. Karlin, 1981 .

BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer

C. Azzoli, K. Russell, J. Hainsworth, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma.

E. Wong, J. Raizer, M. Mrugala, 2018 .

A phase Ib study of pexidartinib (PLX3397) and weekly paclitaxel in patients with advanced solid tumors including an ovarian cancer subset

L. Coussens, H. Rugo, N. Sharma, 2016 .

Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394.

Sunil Sharma, F. Janku, D. Hong, 2018 .

Phase 1 study of picoplatin (pico) in combination with 5-fluorouracil (FU) and leucovorin (LV) as initial therapy in subjects with metastatic colorectal cancer (CRC)

S. Tjulandin, O. Gladkov, D. Karlin, 2007 .

The Gastrointestinal Oncology Clinic: A Multidisciplinary Approach to Cancer Diagnosis and Management at a University Medical Center

I. Rosenberg, B. Levin, J. Kirsner, 1976 .